Statistics for Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization
Total visits
views | |
---|---|
Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization | 213 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
SardarPasha_2018_ref-1.pdf | 242 |
java.util.UUID:ddbdffc1-b32a-4f9d-9e31-9bd48c0f81df | 52 |
java.util.UUID:052547f6-25fe-45e4-93b6-cb2babaef0e9 | 17 |
java.util.UUID:7f78f244-be50-4055-8a5c-26fe98d24116 | 9 |
Top country views
views | |
---|---|
United States | 174 |
Ukraine | 6 |
Germany | 5 |
Russia | 4 |
Canada | 2 |
Uzbekistan | 2 |
China | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 51 |
Fairfield | 34 |
Houston | 15 |
Cambridge | 8 |
Jacksonville | 6 |
Kiev | 6 |
White Plains | 6 |
Kiez | 5 |
Lake Mary | 3 |
Washington | 3 |
Ann Arbor | 2 |
Saint Petersburg | 2 |
San Francisco | 2 |
Tashkent | 2 |
Toronto | 2 |
Beijing | 1 |
Brooklyn | 1 |
Kansas City | 1 |
Moscow | 1 |
Mountain View | 1 |
New York | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |